We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is CVS Health (CVS) Stock Outpacing Its Retail-Wholesale Peers This Year?
Read MoreHide Full Article
Investors focused on the Retail-Wholesale space have likely heard of CVS Health (CVS - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Retail-Wholesale peers, we might be able to answer that question.
CVS Health is a member of the Retail-Wholesale sector. This group includes 219 individual stocks and currently holds a Zacks Sector Rank of #1. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. CVS is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for CVS's full-year earnings has moved 2.32% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
According to our latest data, CVS has moved about 23.40% on a year-to-date basis. Meanwhile, the Retail-Wholesale sector has returned an average of -9.18% on a year-to-date basis. This shows that CVS Health is outperforming its peers so far this year.
Looking more specifically, CVS belongs to the Retail - Pharmacies and Drug Stores industry, which includes 4 individual stocks and currently sits at #233 in the Zacks Industry Rank. On average, stocks in this group have gained 22.92% this year, meaning that CVS is performing better in terms of year-to-date returns.
CVS will likely be looking to continue its solid performance, so investors interested in Retail-Wholesale stocks should continue to pay close attention to the company.
View the Zacks #1 Rank List
Image: Bigstock
Is CVS Health (CVS) Stock Outpacing Its Retail-Wholesale Peers This Year?
Investors focused on the Retail-Wholesale space have likely heard of CVS Health (CVS - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Retail-Wholesale peers, we might be able to answer that question.
CVS Health is a member of the Retail-Wholesale sector. This group includes 219 individual stocks and currently holds a Zacks Sector Rank of #1. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. CVS is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for CVS's full-year earnings has moved 2.32% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
According to our latest data, CVS has moved about 23.40% on a year-to-date basis. Meanwhile, the Retail-Wholesale sector has returned an average of -9.18% on a year-to-date basis. This shows that CVS Health is outperforming its peers so far this year.
Looking more specifically, CVS belongs to the Retail - Pharmacies and Drug Stores industry, which includes 4 individual stocks and currently sits at #233 in the Zacks Industry Rank. On average, stocks in this group have gained 22.92% this year, meaning that CVS is performing better in terms of year-to-date returns.
CVS will likely be looking to continue its solid performance, so investors interested in Retail-Wholesale stocks should continue to pay close attention to the company.